Stockreport

$125M Series A: Ambros Therapeutics to Begin Phase 3 Trials for Non-Opioid Pain Therapy [Los Angeles Times (CA)]

Janus Henderson Group plc Ordinary Shares  (JHG) 
Last janus henderson group plc ordinary shares earnings: 4/30 04:00 am Check Earnings Report
US:NYSE Investor Relations: snl.com/irw/corporateprofile/4147331
PDF therapies for severe, underserved diseases, beginning with neridronate for Complex Regional Pain Syndrome Type 1 (CRPS-1). The round was co-led by RA Capital Managemen [Read more]